Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 98

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 98
---
 Change in Control shall be assumed
by, or replaced with grants that have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation).
In the event that the surviving corporation (or a parent or subsidiary of the surviving corporation) does not assume or replace Awards
with grants that have comparable terms, unless otherwise provided in an Award Agreement, outstanding Stock Options and SARs shall automatically
accelerate and become fully exercisable and the restrictions and conditions on outstanding Stock Awards, Stock Units, Other Stock-Based
Awards and Dividend Equivalents shall immediately lapse, provided that if the vesting of any such Awards is based, in whole or in part,
on performance, such Awards shall vest based on the greater of (i) actual performance as of the Change in Control or (ii) target
performance, pro-rated based on the period elapsed between the beginning of the applicable performance period and the date of the Change
in Control. After a Change in Control, references to the “Company” as they relate to employment matters shall include the
successor employer in the transaction, subject to applicable law.

(b) . At the Committee’s discretion, if Awards are assumed by, or replaced with grants that
have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation) and if a Participant incurs
an involuntary termination of employment or service on or after a Change in Control, the Participant’s outstanding Awards may become
vested, in whole or in part, as of the date of such termination; provided that if the vesting of any such Awards is based, in whole or
in part, on performance, such Awards shall vest only based on the greater of (i) actual performance as of the date of Change in
Control or (ii) target performance, pro-rated based on the period elapsed between the beginning of the applicable performance period
and the date of the termination.

(c) . In the event of a Change in Control, if any outstanding Awards are not assumed by, or replaced with grants that have
comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may take any of
the following actions with respect to any or all outstanding Awards, without the consent of any Participant: (i) the Committee may
determine that Participants shall receive a payment in settlement of outstanding Stock Units, Other Stock-Based Awards or Dividend Equivalents,
in such amount and form as may be determined by the Committee; (ii